Mental Health

The Pharmacy Times® Mental Health Resource Center is a comprehensive resource for clinical news and expert insights on conditions that affect mood, thinking, and behavior, including clinical depression, bipolar disorder, schizophrenia, anxiety, and post-traumatic stress disorder.

Latest News

FDA Breakthrough Therapy Designation Granted to Novel Psychedelic Molecule CYB003 for Major Depressive Disorder
FDA Breakthrough Therapy Designation Granted to Novel Psychedelic Molecule CYB003 for Major Depressive Disorder

March 14th 2024

At 4 months, 75% of participants achieved remission and no longer showed signs of depression symptoms in a phase 2 clinical trial.

Person using semaglutide for weight management -- Image credit: Wild Awake | stock.adobe.com
The Psychological Impact of GLP-1 Receptor Agonists: An Ongoing Investigation

March 13th 2024

Woman suffering from anxiety -- Image credit: Kittiphan | stock.adobe.com
Significant Events Throughout Life Increase Chances For Anxiety, Depression, and Cognitive Decline

March 12th 2024

Image credit: Melita - stock.adobe.com
Navigating Research in Psychedelics: Investigators Face a Mosaic of Regulations, False Perceptions, and Therapeutic Potential

March 11th 2024

Antipsychotic Prescribing Patterns in Pediatric Patients with Major Depressive Disorder
Antipsychotic Prescribing Patterns in Pediatric Patients with Major Depressive Disorder

March 6th 2024

Video Interviews
Podcasts
Pharmacy Focus: Psychedelic Pharmacy logo

More News

© 2024 MJH Life Sciences

All rights reserved.